Eli Lilly’s obesity and diabetes treatments fuel growth and spark bidding war

U.S. sales of Lilly’s weight-loss treatment Zepbound nearly tripled to $3.57 billion in the third quarter. Meanwhile, revenue ...

Eli Lilly Stock Rises on Earnings as Investors Await Trump Drug Pricing Deal

Revenue from Mounjaro, the company’s Type 2 diabetes treatment, came in at $6.5 billion, above analysts’ consensus estimate ...
Fierce Biotech

Eli Lilly sidelines midstage prospect in another pain pipeline pivot

In parallel with mazisotine’s shelving, Lilly added a phase 1 NaV1.8 inhibitor from its SiteOne Therapeutics acquisition to ...

Eli Lilly: The Price Upside Just Increased

Eli Lilly reported strong earnings and raised guidance. Read more on what could be next for this biotech giant.
24/7 Wall St.

Eli Lilly Blows Away Q3 Earnings Expectations

The Big Pharma mainstay blew away EPS and revenue expectations when it reported Q3 financials, with management raising ...

Eli Lilly to invest $1.2 billion in Puerto Rico as part of US manufacturing push

Eli Lilly said on Wednesday it will invest more than $1.2 billion to expand its manufacturing site in Puerto Rico, as the ...
Fierce Biotech

Eli Lilly and Nvidia team up to build 'most powerful' supercomputer in pharma

Eli Lilly and computing giant Nvidia are teaming up to build a new supercomputer that the pair say will be the most powerful owned and operated by a pharmaceutical company.
Fierce Pharma

Eli Lilly teams up with basketball legend Shaquille O'Neal to take sleep apnea awareness campaign to new heights

In its mission to enlighten others to the symptoms of obstructive sleep apnea (OSA), Eli Lilly is getting an assist from NBA ...